OpenVSafe by OpenVAERS
Search V-safe

PGF-29951-28232

3 vaccinations 4 coded responses 15 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
080 / NJ
Registered
2021-10-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-17
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-21
    Registered in v-safe
  4. 2022-01-06
    Dose 3 — Moderna
  5. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2022-01-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Pain in underarm gland
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-01-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Muscle or body aches
    Free text: Pain in gland in underarm
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-01-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2022-01-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Chills, Headache
    Adult check-in
  10. 2022-01-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2022-01-13
    Survey response — day 7, dose 3
    MedDRA: Exposure to SARS-CoV-2 — Feeling: Fair · Fatigue or tiredness
    Free text: Exposed to covid
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-20
    Survey response — day 14, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Possible covid infection
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-01-20
    Report sent to call center — day 14, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-01-21
  15. 2022-01-29
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-03
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-12
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-02-19
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-04-07
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-07-13
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  21. 2023-01-06
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-27Pfizer-BioNTech No
22021-02-17Pfizer-BioNTech No
32022-01-06Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2022-01-08

Systemic reaction (other): Pain in underarm gland

2022-01-09

Systemic reaction (other): Pain in gland in underarm

Release 10 — day 7, dose 3

2022-01-13

Systemic reaction (other): Exposed to covid

Release 10 — day 14, dose 3

2022-01-20

Symptoms: Possible covid infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDUnevaluable event · · ✓
SROExposure to SARS-CoV-2 · · ✓
SROLymph node pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release